Güç Esra, Pollard Jeffrey W
MRC Centre for Reproductive Health, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
MRC Centre for Reproductive Health, Queen's Medical Research Institute, The University of Edinburgh, Edinburgh, UK.
Immunity. 2021 May 11;54(5):885-902. doi: 10.1016/j.immuni.2021.03.022.
Tumor cells metastasize to distant organs through a complex series of events that are driven by tumor intrinsic and extrinsic factors. In particular, non-malignant stromal cells, including immune cells, modify tumor metastatic behavior. Of these cells, tumor-associated innate immune cells, particularly macrophages and neutrophils, suppress the cytotoxic activity of innate and adaptive killer cells and interact with tumor cells to promote their growth and malignancy. These findings in mouse cancer models suggest that targeting these sub-populations of immune cells holds therapeutic promise in treating metastatic disease. In this review, we describe the origin and role of the macrophages, neutrophils, and their progenitors in the metastatic cascade and suggest strategies that might enhance cancer therapy.
肿瘤细胞通过一系列由肿瘤内在和外在因素驱动的复杂事件转移至远处器官。特别是包括免疫细胞在内的非恶性基质细胞会改变肿瘤的转移行为。在这些细胞中,肿瘤相关固有免疫细胞,尤其是巨噬细胞和中性粒细胞,会抑制固有和适应性杀伤细胞的细胞毒性活性,并与肿瘤细胞相互作用以促进其生长和恶性转化。小鼠癌症模型中的这些发现表明,针对这些免疫细胞亚群进行治疗有望治愈转移性疾病。在本综述中,我们描述了巨噬细胞、中性粒细胞及其祖细胞在转移级联反应中的起源和作用,并提出了可能增强癌症治疗效果的策略。